Rxo (RXO) Gains from Investment Securities (2021 - 2026)

Rxo (RXO) has reported Gains from Investment Securities for 6 consecutive years, with $9.0 million the latest figure, recorded in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $9.0 million, down 47.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 117.39% YoY), and the FY2025 annual result was $4.0 million, changed 0.0% from the prior year.
• Gains from Investment Securities was $9.0 million for Q1 2026 at Rxo, up from -$1.0 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $37.0 million in Q2 2023 and troughed at -$69.0 million in Q4 2023.
• Average Gains from Investment Securities over 5 years is $846153.8, with a median of $2.0 million recorded in 2024.
• Year-over-year, Gains from Investment Securities sank 2400.0% in 2023 and soared 950.0% in 2025.
• Over 5 years, Gains from Investment Securities stood at $3.0 million in 2022, then tumbled by 2400.0% to -$69.0 million in 2023, then soared by 110.14% to $7.0 million in 2024, then sank by 114.29% to -$1.0 million in 2025, then jumped by 1000.0% to $9.0 million in 2026.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were $9.0 million in Q1 2026, -$1.0 million in Q3 2025, and -$12.0 million in Q2 2025.